Enanta Pharmaceuticals (ENTA) Non-cash Items (2012 - 2026)

Enanta Pharmaceuticals has reported Non-cash Items for 15 years, with the latest figure at $7.7 million in Q1 2026.

• For the quarter ending Q1 2026, Non-cash Items changed N/A year-over-year to $7.7 million; the trailing twelve-month figure through Mar 2026 stood at $7.7 million (changed N/A YoY), and the FY2025 full-year result was $4.0 million, up 16.03% from the prior year.
• Non-cash Items for Q1 2026 stood at $7.7 million, down from $16.9 million in the prior quarter.
• The five-year high for Non-cash Items was $83.0 million in Q1 2022, with the low at $1.4 million in Q3 2024.
• Historically, Non-cash Items has averaged $14.8 million across 5 years, with a median of $7.1 million in 2025.
• Annual changes were most pronounced in 2022 — Non-cash Items jumped 3489.84% — and 2023, when it tumbled 96.63%.
• Enanta Pharmaceuticals' Non-cash Items stood at $17.6 million in 2022, then sank by 82.84% to $3.0 million in 2023, then slumped by 53.24% to $1.4 million in 2024, then jumped by 1095.83% to $16.9 million in 2025, then slumped by 54.58% to $7.7 million in 2026.
• The last three Non-cash Items figures came in at $7.7 million (Q1 2026), $16.9 million (Q4 2025), and $6.5 million (Q3 2025), per Business Quant data.